Net Net Stock Overview

Subscribe

To see hundreds more international net nets, consider subscribing

Overview

Rapid Micro Biosystems Inc
Healthcare
P/NCAV
0.42x
Ticker
RPID
Exchange
NASDAQ
Country
United States
Close
0.93 $
Mkt Cap
40.0M $
EV
16.0M $
NCAV Burn Rate
15.3%
Current Ratio
6.34
Debt/Equity
0.0
EV/REV
0.71x
EV/EBIT
-0.3x
EV/FCF
-0.4x
Dilution
1.8% p.A
Total Net Income
-245.0M $
Cheapness
100.0%
Rapid Micro Biosystems, Inc. is a life sciences technology company providing mission critical automation solutions to facilitate the manufacturing and release of healthcare products, such as biologics, vaccines, cell and gene therapies, and sterile injectables. The Company-s flagship Growth Direct system automates and modernizes the antiquated, manual microbial quality control, testing workflows used in pharmaceutical manufacturing operations. It offers four specific applications for testing of microbial contamination: Environmental Monitoring, which tests the manufacturing environment, including circulating air, exposed surfaces, and personnel; Water, which tests any purified water used at any stage of the drug production process, including water for injection; In-Process Bioburden, which tests raw materials, drug substance and in-process product, and Sterility Release offering final testing of finished product to ensure sterility before the product is released for commercial sale.

Profitability

positive values --- Average negative values

Margins

--- Average

Valuation

positive values --- Average negative values

Dilution

--- Average